Edwards Lifesciences Total Assets 2010-2024 | EW

Edwards Lifesciences total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Edwards Lifesciences total assets for the quarter ending September 30, 2024 were $12.971B, a 38.42% increase year-over-year.
  • Edwards Lifesciences total assets for 2023 were $9.363B, a 12.91% increase from 2022.
  • Edwards Lifesciences total assets for 2022 were $8.293B, a 2.47% decline from 2021.
  • Edwards Lifesciences total assets for 2021 were $8.503B, a 17.49% increase from 2020.
Edwards Lifesciences Annual Total Assets
(Millions of US $)
2023 $9,363
2022 $8,293
2021 $8,503
2020 $7,237
2019 $6,488
2018 $5,324
2017 $5,666
2016 $4,510
2015 $4,056
2014 $3,523
2013 $2,710
2012 $2,222
2011 $1,981
2010 $1,767
2009 $1,616
Edwards Lifesciences Quarterly Total Assets
(Millions of US $)
2024-09-30 $12,971
2024-06-30 $10,099
2024-03-31 $9,736
2023-12-31 $9,363
2023-09-30 $9,371
2023-06-30 $9,004
2023-03-31 $8,651
2022-12-31 $8,293
2022-09-30 $8,638
2022-06-30 $8,425
2022-03-31 $8,420
2021-12-31 $8,503
2021-09-30 $8,160
2021-06-30 $7,662
2021-03-31 $7,214
2020-12-31 $7,237
2020-09-30 $6,801
2020-06-30 $6,424
2020-03-31 $6,076
2019-12-31 $6,488
2019-09-30 $5,966
2019-06-30 $5,574
2019-03-31 $5,469
2018-12-31 $5,324
2018-09-30 $5,958
2018-06-30 $5,686
2018-03-31 $5,825
2017-12-31 $5,666
2017-09-30 $5,488
2017-06-30 $5,139
2017-03-31 $4,780
2016-12-31 $4,510
2016-09-30 $4,339
2016-06-30 $4,051
2016-03-31 $3,854
2015-12-31 $4,056
2015-09-30 $3,877
2015-06-30 $3,608
2015-03-31 $3,488
2014-12-31 $3,523
2014-09-30 $3,350
2014-06-30 $3,327
2014-03-31 $2,652
2013-12-31 $2,710
2013-09-30 $2,531
2013-06-30 $2,340
2013-03-31 $2,297
2012-12-31 $2,222
2012-09-30 $2,196
2012-06-30 $2,075
2012-03-31 $2,004
2011-12-31 $1,981
2011-09-30 $1,983
2011-06-30 $2,002
2011-03-31 $1,931
2010-12-31 $1,767
2010-09-30 $1,725
2010-06-30 $1,642
2010-03-31 $1,604
2009-12-31 $1,616
2009-09-30 $1,602
2009-06-30 $1,465
2009-03-31 $1,359
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.569B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $196.322B 23.95
Intuitive Surgical (ISRG) United States $195.140B 102.02
Alcon (ALC) Switzerland $42.414B 28.38
IQVIA Holdings (IQV) United States $36.630B 20.18
IDEXX Laboratories (IDXX) United States $34.166B 40.24
DexCom (DXCM) United States $28.447B 42.84
Waters (WAT) United States $22.175B 32.79
STERIS (STE) Ireland $21.157B 24.36
SONOVA HOLDING (SONVY) Switzerland $20.795B 0.00
Hologic (HOLX) United States $18.343B 19.36
Fresenius Medical Care AG KGaA (FMS) Germany $13.004B 13.35
Sysmex ADR (SSMXY) Japan $12.946B 40.60
Globus Medical (GMED) United States $11.536B 29.21
Penumbra (PEN) United States $9.397B 92.05
Masimo (MASI) United States $9.260B 44.81
Teleflex (TFX) United States $8.904B 14.20
Glaukos (GKOS) United States $7.940B 0.00
PROCEPT BioRobotics (PRCT) United States $4.884B 0.00
Integer Holdings (ITGR) United States $4.632B 26.26
Veracyte (VCYT) United States $3.068B 92.07
Inari Medical (NARI) United States $2.907B 0.00
LivaNova (LIVN) United Kingdom $2.787B 16.09
TransMedics (TMDX) United States $2.552B 80.89
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.167B 17.66
Tandem Diabetes Care (TNDM) United States $2.024B 0.00
Integra LifeSciences Holdings (IART) United States $1.820B 9.51
RxSight (RXST) United States $1.807B 0.00
Alphatec Holdings (ATEC) United States $1.427B 0.00
Artivion (AORT) United States $1.185B 78.53
Pulse Biosciences (PLSE) United States $1.088B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 14.53
Paragon 28 (FNA) United States $0.841B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.723B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.638B 0.00
Mesa Laboratories (MLAB) United States $0.593B 13.97
AxoGen (AXGN) United States $0.587B 0.00
SiBone (SIBN) United States $0.527B 0.00
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.488B 0.00
Semler Scientific (SMLR) United States $0.462B 31.05
Tactile Systems Technology (TCMD) United States $0.428B 23.18
CVRx (CVRX) United States $0.360B 0.00
ClearPoint Neuro (CLPT) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.312B 0.00
NeuroPace (NPCE) United States $0.290B 0.00
AngioDynamics (ANGO) United States $0.278B 0.00
Inogen (INGN) United States $0.223B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
Accuray (ARAY) United States $0.194B 0.00
Nevro (NVRO) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.60
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Neuronetics (STIM) United States $0.027B 0.00
NexGel (NXGL) United States $0.023B 0.00
Spectral AI (MDAI) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00